Search research articles
Contact Us
Filters
Showing results (111-120 of 181) with videos related to
Page
of 19
Sort By:
Arthritis and Rheumatism
|
December 17, 2010
Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus
Corinna E Weckerle, Beverly S Franek, Jennifer A Kelly, et al.
The Journal of Rheumatology
|
November 3, 2016
Gene Expression Profiling in Blood and Affected Muscle Tissues Reveals Differential Activation Pathways in Patients with New-onset Juvenile and Adult Dermatomyositis
Consuelo M López De Padilla, Cynthia S Crowson, Molly S Hein, et al.
Lupus Science & Medicine
|
December 15, 2017
Single-cell gene expression patterns in lupus monocytes independently indicate disease activity, interferon and therapy
Zhongbo Jin, Wei Fan, Mark A Jensen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 8, 2017
Brief Report: A Novel ELANE Mutation Associated With Inflammatory Arthritis, Defective NETosis, and Recurrent Parvovirus Infection
Uma Thanarajasingam, Mark A Jensen, Jessica M Dorschner, et al.
Arthritis Research & Therapy
|
May 1, 2021
Proteome study of cutaneous lupus erythematosus (CLE) and dermatomyositis skin lesions reveals IL-16 is differentially upregulated in CLE
Timothy B Niewold, Alexander Meves, Julia S Lehman, et al.
Annals of the Rheumatic Diseases
|
April 19, 2016
Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification
Melissa E Munroe, Rufei Lu, Yan D Zhao, et al.
ACR Open Rheumatology
|
November 29, 2019
Type I Interferon Predicts an Alternate Immune System Phenotype in Systemic Lupus Erythematosus
Uma Thanarajasingam, Anoohya N Muppirala, Mark A Jensen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 9, 2021
Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19
Ilona Nln, Ruth Fernandez-Ruiz, Theresa L Wampler Muskardin, et al.
Plos One
|
February 9, 2010
Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations
Nadera J Sweiss, Rafah Salloum, Seema Gandhi, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
February 3, 2022
Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19
Ilona Nln, Ruth Fernandez-Ruiz, Theresa L Wampler Muskardin, et al.
Page
of 19
Search research articles
Search
Showing results (111-120 of 181) with videos related to
Sort By:
Page
of 19
Arthritis and Rheumatism
|
December 17, 2010
Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus
Corinna E Weckerle, Beverly S Franek, Jennifer A Kelly, et al.
The Journal of Rheumatology
|
November 3, 2016
Gene Expression Profiling in Blood and Affected Muscle Tissues Reveals Differential Activation Pathways in Patients with New-onset Juvenile and Adult Dermatomyositis
Consuelo M López De Padilla, Cynthia S Crowson, Molly S Hein, et al.
Lupus Science & Medicine
|
December 15, 2017
Single-cell gene expression patterns in lupus monocytes independently indicate disease activity, interferon and therapy
Zhongbo Jin, Wei Fan, Mark A Jensen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 8, 2017
Brief Report: A Novel ELANE Mutation Associated With Inflammatory Arthritis, Defective NETosis, and Recurrent Parvovirus Infection
Uma Thanarajasingam, Mark A Jensen, Jessica M Dorschner, et al.
Arthritis Research & Therapy
|
May 1, 2021
Proteome study of cutaneous lupus erythematosus (CLE) and dermatomyositis skin lesions reveals IL-16 is differentially upregulated in CLE
Timothy B Niewold, Alexander Meves, Julia S Lehman, et al.
Annals of the Rheumatic Diseases
|
April 19, 2016
Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification
Melissa E Munroe, Rufei Lu, Yan D Zhao, et al.
ACR Open Rheumatology
|
November 29, 2019
Type I Interferon Predicts an Alternate Immune System Phenotype in Systemic Lupus Erythematosus
Uma Thanarajasingam, Anoohya N Muppirala, Mark A Jensen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 9, 2021
Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19
Ilona Nln, Ruth Fernandez-Ruiz, Theresa L Wampler Muskardin, et al.
Plos One
|
February 9, 2010
Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations
Nadera J Sweiss, Rafah Salloum, Seema Gandhi, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
February 3, 2022
Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19
Ilona Nln, Ruth Fernandez-Ruiz, Theresa L Wampler Muskardin, et al.
Page
of 19